fashion -WSS

fashion

author：comprehensive 2025-10-06 15:49:10 - browse：85

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter:

In December, Vertex Pharmaceuticalsannounced results from a mid-stage clinical trial showing its experimental, non-opioid drug reduced pain in people with diabetes who have chronic pain. This quarter, the company will read out results from Phase 3 studies of the same pain drug, called VX-548, in people with acute pain following surgery.

The next big test of Alnylam Pharmaceuticals’pipeline of RNA-interference medicines looms with the outcome of a Phase 3 study called HELIOS-B that is investigating vutrisiran as a treatment for ATTR-CM, a progressive disease that leads to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： What to expect at HLTH 2023, the health care industry conference

knowledge

WSS

3 questions for the future of Biden's cancer moonshot

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Senate panel eyes new effort on drug shortages

Chan Zuckerberg Biohub Chicago to focus on inflammation

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Phenylephrine and the overlooked value of the placebo effect

hotspot

fashion

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

UnitedHealth quietly bought dozens of outpatient centers

Malaria cases in Florida and Texas: Here’s what you need to know

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Virginia high school admissions case could be legal follow

Sen. Paul opposes bill to ban Chinese biotechs

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

As demand for Covid shots wanes, Moderna seeks its next success

The drug industry has found itself all alone in Washington

focus

Novo Nordisk obesity pill bests Wegovy in early trial

Headspace, Meta partner to launch VR meditation app for Quest

Liquid biopsy for lung cancer is launched by Delfi

Headspace, Meta partner to launch VR meditation app for Quest

A virus, fished out of a lake, may have saved a man’s life

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

knowledge

hotspot

hotspot

knowledge